American Century Companies »

Rapt Therapeutics shares owned by American Century Companies

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by American Century Companies from 13F filings

Historical chart of American Century Companies investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by American Century Companies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by American Century Companies

Quarter filed Position value Share count Share price at filing
2025-12-31 $346k 10k 33.87

More positions owned by American Century Companies

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Eli Lilly & Co. (LLY)
Netflix (NFLX)
Costco Wholesale Corporation (COST)
JPMorgan Chase & Co. (JPM)

View all positions for American Century Companies

Top funds holding Rapt Therapeutics

TCG Crossover Management
Fcpm Iii Services B.v.
OrbiMed Advisors
Rtw Investments
Foresite Capital Management VI
Siren
Vanguard Group
Frazier Life Sciences Management
Ikarian Capital
Braidwell
Soleus Capital Management
Nantahala Capital Management
Caligan Partners
State Street Corporation
Dr. Jeffrey R. Jay, M.D.

View all funds holding Rapt Therapeutics